Search Results 961-970 of 17586 for Assay

1. Light Chain Amyloidosis Maintenance Evaluation - Mayo Clinic

   Patients must have monoclonal protein studies (serum free light chain assay, serum immunofixation or serum MASS-FIX) obtained at time of diagnosis before ...

2. Hepatitis C Therapeutic Registry and Research Network - Mayo Clinic

   Studies comparing HCV RNA assays are not considered exclusionary. Participating Mayo Clinic locations. Study statuses change often. Please contact the study ...

3. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

   Has laboratory-confirmed (within 14 days prior to enrollment) SARS-CoV-2 infection as determined by PCR or other commercial or public health assay in any ...

4. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

   Measurable disease defined as the finding by serum-free light chain (FLC) assay that the difference between the involved and uninvolved FLC (dFLC) is ≥ 50 mg/L ...

5. Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) Infection of the Lower Respiratory Tract - Mayo Clinic

   ... assay, or culture). All samples must have been collected ≤ 6 days prior to Day 1, or as determined at screening as per protocol. An informed consent ...

6. A Study Of GC012F (AZD0120), A CAR T Therapy Targeting CD19 And BCMA In Subjects With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

   ... assay: involved FLC level is ≥10 mg/dL (100 mg/L) and serum kappa lambda FLC ratio is abnormal. * Adequate bone marrow and organ function assessment at ...

7. A Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas - Mayo Clinic

   ... assay for active, GTP-bound Ras. In NIH 3T3 cells, the assay detected overexpressed, constitutively activated K-, N-, and Ha-Ras and insulin-induced ...

8. Testing The Addition Of An Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery To The Usual Surgery Alone For Treating Advanced Skin Cancer - Mayo Clinic

   ... assay demonstrating a high tumor mutation burden (≥ 10 mutations/Mb) and/or a high fraction of ultraviolet (UV) related mutations (> 50% of mutations ...

9. Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) - Mayo Clinic

   nti-BP180 or anti-BP230 antibody positive by enzyme linked immunosorbent assay. Note, if the serum binds both the epidermal and dermal side of the salt ...

10. Testing Teclistamab (TECVAYLI) In Combination With Iberdomide For Hard-to-Treat Multiple Myeloma - Mayo Clinic

    * Serum free light chain (FLC) assay: "involved" FLC level ≥ 10 mg/dL ( ≥ 100 mg/L) and an abnormal serum free light chain ratio ( \< 0.26 or \> 1.65) * ...